Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3709619016 | Product containing dinoprostone in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3709620010 | Dinoprostone-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4543641000052118 | läkemedel som innehåller dinoproston, parenteral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing dinoprostone in parenteral dose form (medicinal product form) | Is a | Product containing dinoprostone (medicinal product) | true | Inferred relationship | Some | ||
| Product containing dinoprostone in parenteral dose form (medicinal product form) | Has active ingredient | Prostaglandin PGE>2< | false | Inferred relationship | Some | ||
| Product containing dinoprostone in parenteral dose form (medicinal product form) | Has active ingredient | Prostaglandin E>1< | false | Inferred relationship | Some | ||
| Product containing dinoprostone in parenteral dose form (medicinal product form) | Has active ingredient | Dinoprostone (substance) | true | Inferred relationship | Some | 1 | |
| Product containing dinoprostone in parenteral dose form (medicinal product form) | Has active ingredient | Posterior pituitary hormone | false | Inferred relationship | Some | ||
| Product containing dinoprostone in parenteral dose form (medicinal product form) | Has manufactured dose form | för injektion | false | Inferred relationship | Some | ||
| Product containing dinoprostone in parenteral dose form (medicinal product form) | Has active ingredient | Alprostadil | false | Inferred relationship | Some | ||
| Product containing dinoprostone in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing dinoprostone in parenteral dose form (medicinal product form) | Is a | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| Product containing dinoprostone in parenteral dose form (medicinal product form) | Plays role | Oxytocic therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| dinoproston 1 mg/ml, infusionskoncentrat, ampull 0,75 ml | Is a | False | Product containing dinoprostone in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| dinoproston 10 mg/ml, infusionskoncentrat, ampull 0,5 ml | Is a | False | Product containing dinoprostone in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| dinoproston 10 mg/ml, injektionskoncentrat, ampull 0,5 ml med spädningsvätska | Is a | False | Product containing dinoprostone in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| dinoproston 5 mg/0,5 ml, infusionsväska, lösning, ampull | Is a | False | Product containing dinoprostone in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| dinoproston 750 mikrogram/0,75 ml, infusionsväska, lösning, ampull | Is a | False | Product containing dinoprostone in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| Dinoprostone only product in parenteral dose form | Is a | True | Product containing dinoprostone in parenteral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR